CGTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.75%

Insider Buying (Last 12 Months): $9,975.00

Insider Selling (Last 12 Months): $0.00

Cognition Therapeutics Insider Trading History Chart

Cognition Therapeutics Share Price & Price History

^$0.46

▼ -0.05 (-9.78%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

Financial Prophecy

From Porter & Company | Ad

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Cognition Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2024	Lisa Ricciardi	CEO	Buy	5,700	$1.75	$9,975.00	291,345
11/29/2022	Ellen B Richstone	Director	Buy	10,000	$2.65	$26,500.00	10,000
11/15/2022	Lisa Ricciardi	CEO	Buy	12,000	$1.30	$15,600.00	24,500
11/15/2022	Peggy Wallace	Director	Buy	12,500	$1.20	$15,000.00	37,961

The Crypto That’s Making Wall Street Sweat

From Crypto 101 Media | Ad

The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.

Click here to discover our #1 crypto for the market right now – poised for massive growth

SEC Filings (Institutional Ownership Changes) for Cognition Therapeutics (NASDAQ:CGTX)

43.35% of Cognition Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cognition Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/4/2024	Sigma Planning Corp	197,190	$92K	0.0%	+14.6%	0.491%
8/12/2024	Mercer Global Advisors Inc. ADV	95,951	$0.16M	0.0%	+33.4%	0.240%
8/9/2024	Renaissance Technologies LLC	89,718	$0.15M	0.0%	-42.4%	0.224%
8/7/2024	AIGH Capital Management LLC	300,766	$0.50M	0.2%	-84.1%	0.751%
8/2/2024	CM Management LLC	200,000	$0.33M	0.3%	+14.3%	0.499%
7/16/2024	Bangor Savings Bank	34,019	$56K	0.0%	+41.6%	0.085%
5/16/2024	Levin Capital Strategies L.P.	30,000	$55K	0.0%	N/A	0.075%
5/16/2024	AWM Investment Company Inc.	650,000	$1.18M	0.2%	N/A	1.623%
5/14/2024	Carlson Capital L P	213,995	$0.39M	0.0%	-10.1%	0.534%
5/14/2024	CM Management LLC	175,000	$0.32M	0.3%	N/A	0.437%
5/10/2024	Tocqueville Asset Management L.P.	26,000	$47K	0.0%	N/A	0.065%
5/8/2024	Hohimer Wealth Management LLC	225,000	$0.41M	0.1%	N/A	0.562%
3/5/2024	Twin Focus Capital Partners LLC	93,372	$0.17M	0.0%	N/A	0.291%
2/8/2024	Texas Capital Bank Wealth Management Services Inc	55,395	$0.10M	0.0%	N/A	0.172%
2/1/2024	Sigma Planning Corp	28,550	$53K	0.0%	N/A	0.089%
10/23/2023	Steward Financial Group LLC	40,874	$58K	0.0%	N/A	0.135%
7/28/2023	Voss Capital LLC	60,222	$0.11M	0.0%	-62.4%	0.206%
5/12/2023	Voss Capital LLC	159,973	$0.32M	0.0%	-4.2%	0.546%
5/12/2023	FCA Corp TX	51,471	$0.10M	0.0%	N/A	0.176%
2/16/2023	AIGH Capital Management LLC	2,037,853	$4.28M	1.4%	+155.3%	7.030%
2/13/2023	Northeast Financial Consultants Inc	24,500	$51K	0.0%	N/A	0.085%
2/13/2023	Voss Capital LLC	166,903	$0.35M	0.1%	-23.8%	0.576%
2/13/2023	Financial Partners Capital Management LLC	14,228	$30K	0.0%	N/A	0.049%
2/7/2023	Commonwealth Equity Services LLC	189,307	$0.40M	0.0%	-13.6%	0.653%
2/6/2023	Neumann Capital Management LLC	33,382	$70K	0.0%	N/A	0.115%
1/31/2023	Kestra Advisory Services LLC	50,618	$0.11M	0.0%	+237.5%	0.175%
1/20/2023	Diligent Investors LLC	20,000	$42K	0.0%	-34.5%	0.069%
12/13/2022	Perigon Wealth Management LLC	36,900	$70K	0.0%	-70.0%	0.127%
11/15/2022	Carlson Capital L P	100,000	$0.19M	0.0%	N/A	0.440%
11/14/2022	Worth Venture Partners LLC	200,188	$0.38M	0.2%	-12.3%	0.881%
11/10/2022	Rock Creek Group LP	50,000	$95K	0.0%	-37.3%	0.220%
11/2/2022	Voss Capital LLC	219,100	$0.42M	0.1%	-29.2%	0.965%
11/1/2022	P.A.W. Capital Corp	100,000	$0.19M	0.3%	-25.9%	0.440%
10/12/2022	Wealth Alliance Advisory Group LLC	18,500	$35K	0.0%	N/A	0.081%
8/13/2022	Voss Capital LLC	309,472	$0.65M	0.2%	+1,070.5%	1.363%
8/13/2022	Prosight Management LP	120,198	$0.25M	0.2%	-49.9%	0.532%
8/11/2022	Perigon Wealth Management LLC	122,846	$0.26M	0.0%	N/A	0.544%
8/8/2022	Rock Creek Group LP	79,751	$0.17M	0.0%	+201.6%	0.353%
8/1/2022	Castle Wealth Management LLC	43,380	$92K	0.1%	N/A	0.192%
7/19/2022	Commonwealth Equity Services LLC	214,961	$0.45M	0.0%	+1,447.6%	0.951%
7/13/2022	P.A.W. Capital Corp	135,000	$0.29M	0.4%	+12.5%	0.597%
5/17/2022	Prosight Management LP	240,080	$0.66M	0.4%	-20.5%	1.062%
5/4/2022	Commonwealth Equity Services LLC	13,890	$38K	0.0%	N/A	0.061%
4/26/2022	Diligent Investors LLC	30,520	$84K	0.0%	N/A	0.135%
4/26/2022	Kestra Advisory Services LLC	238,666	$0.66M	0.0%	+150.9%	1.057%
4/21/2022	P.A.W. Capital Corp	120,000	$0.33M	0.3%	+20.0%	0.531%
4/14/2022	Bangor Savings Bank	18,496	$51K	0.0%	N/A	0.082%
2/10/2022	B. Riley Financial Inc.	30,904	$0.20M	0.0%	N/A	0.140%
2/10/2022	American Financial Group Inc.	205,000	$1.30M	0.4%	N/A	0.930%
2/10/2022	AIGH Capital Management LLC	25,496	$0.16M	0.0%	N/A	0.116%
2/10/2022	P.A.W. Capital Corp	100,000	$0.63M	0.6%	N/A	0.454%

Data available starting January 2016

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.

Today's Range

Now: $0.46

$0.46

$0.51

50 Day Range

MA: $0.50

$0.40

$0.61

52 Week Range

Now: $0.46

$0.34

$2.95

Volume

336,050 shs

Average Volume

654,864 shs

Market Capitalization

$19.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Cognition Therapeutics?: Cognition Therapeutics' top insider investors include:
Lisa Ricciardi (CEO)
Ellen B Richstone (Director)
Learn More about top insider investors at Cognition Therapeutics.
Who are the major institutional investors of Cognition Therapeutics?: Cognition Therapeutics' top institutional shareholders include:
Sigma Planning Corp — 0.49%
Learn More about top institutional investors of Cognition Therapeutics stock.
Which institutional investors are buying Cognition Therapeutics stock?: During the previous quarter, CGTX stock was purchased by institutional investors including:
Sigma Planning Corp
In the previous year, these company insiders have bought Cognition Therapeutics stock:
Lisa Ricciardi (CEO)
Ellen B Richstone (Director)
Learn More investors buying Cognition Therapeutics stock.